Previous studies have shown that the crosslinking of CD33 by monoclonal antibody induces apoptosis in AML cells and inhibits the in vitro proliferation of both normal myeloid cells and chronic myeloid leukemia [15]. This evidence concerns the gene CD33 and chronic myelogenous leukemia, BCR-ABL1 positive.